mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [

Carbon Radioisotopes Electroencephalography Humans Oximes Positron-Emission Tomography Pyridines Receptor, Metabotropic Glutamate 5

Journal

Translational psychiatry

ISSN: 2158-3188

Titre abrégé: Transl Psychiatry

Pays: United States

ID NLM: 101562664

Informations de publication

Date de publication:
10 01 2022

Historique:

received: 12 07 2021

accepted: 30 11 2021

revised: 22 11 2021

entrez: 11 1 2022

pubmed: 12 1 2022

medline: 1 2 2022

Statut: epublish

Résumé

Currently, the metabotropic glutamate receptor 5 (mGluR5) is the subject of several lines of research in the context of neurology and is of high interest as a target for positron-emission tomography (PET). Here, we assessed the feasibility of using [

Identifiants

DOI: 10.1038/s41398-021-01763-3 PMID: 35013095 PMC: PMC8748790

pubmed: 35013095

doi: 10.1038/s41398-021-01763-3

pii: 10.1038/s41398-021-01763-3

pmc: PMC8748790

doi:

Substances chimiques

3-(6-methylpyridin-2-ylethynyl)cyclohex-2-enone-O-methyloxime 0

Carbon Radioisotopes 0

GRM5 protein, human 0

Oximes 0

Pyridines 0

Receptor, Metabotropic Glutamate 5 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

Pagination

Informations de copyright

Références

Purves D, Augustine G, Fitzpatrick D, Katz L, LaMantia AS, McNamara JO, et al. Neuroscience. edition n, editor. Sunderland (MA): Sinauer Associates; 2001.

Akkus F, Treyer V, Ametamey SM, Johayem A, Buck A, Hasler G. Metabotropic glutamate receptor 5 neuroimaging in schizophrenia. Schizophr Res 2017;183:95–101.

pubmed: 27847228 doi: 10.1016/j.schres.2016.11.008

Akkus F, Mihov Y, Treyer V, Ametamey SM, Johayem A, Senn S, et al. Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder. Transl Psychiatry 2018;8:17.

pubmed: 29317611 pmcid: 5802584 doi: 10.1038/s41398-017-0066-6

Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 2008;7:426–37.

pubmed: 18425072 pmcid: 2715836 doi: 10.1038/nrd2462

Milella MS, Marengo L, Larcher K, Fotros A, Dagher A, Rosa-Neto P, et al. Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [11C]ABP688 study. Neuroimage 2014;98:195–202.

pubmed: 24795154 doi: 10.1016/j.neuroimage.2014.04.061

DeLorenzo C, Sovago J, Gardus J, Xu J, Yang J, Behrje R, et al. Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [11C]ABP688. Transl Psychiatry 2015;5:e693.

pubmed: 26645628 pmcid: 5068588 doi: 10.1038/tp.2015.189

Pillai RLI, Tipre DN. Metabotropic glutamate receptor 5 – a promising target in drug development and neuroimaging. Eur J Nucl Med Mol Imaging 2016;43:1151–70.

pubmed: 26743895 doi: 10.1007/s00259-015-3301-5

Miyake N, Skinbjerg M, Easwaramoorthy B, Kumar D, Girgis RR, Xu X, et al. Imaging changes in glutamate transmission in vivo with the metabotropic glutamate receptor 5 tracer [11C] ABP688 and N-acetylcysteine challenge. Biol Psychiatry 2011;69:822–4.

pubmed: 21288506 doi: 10.1016/j.biopsych.2010.12.023

Ametamey SM, Kessler LJ, Honer M, Wyss MT, Buck A, Hintermann S, et al. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J Nucl Med 2006;47:698–705.

pubmed: 16595505

DeLorenzo C, DellaGioia N, Bloch M, Sanacora G, Nabulsi N, Abdallah C, et al. In vivo ketamine-induced changes in [11C]ABP688 binding to metabotropic glutamate receptor subtype 5. Biol Psychiatry 2015;77:266–75.

pubmed: 25156701 doi: 10.1016/j.biopsych.2014.06.024

Esterlis I, DellaGioia N, Pietrzak RH, Matuskey D, Nabulsi N, Abdallah CG, et al. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression. Mol Psychiatry 2018;23:824–32.

pubmed: 28397841 doi: 10.1038/mp.2017.58

Holmes SE, Gallezot J-D, Davis MT, DellaGioia N, Matuskey D, Nabulsi N, et al. Measuring the effects of ketamine on mGluR5 using [18F]FPEB and PET. J Cereb Blood Flow Metab 2019;40:2254–64.

pubmed: 31744389 pmcid: 7585925 doi: 10.1177/0271678X19886316

Nagai T, Kirihara K, Tada M, Koshiyama D, Koike S, Suga M, et al. Reduced mismatch negativity is associated with increased plasma level of glutamate in first-episode psychosis. Sci Rep. 2017;7:2258.

pubmed: 28536477 pmcid: 5442101 doi: 10.1038/s41598-017-02267-1

Naatanen R, Paavilainen P, Tiitinen H, Jiang D, Alho K. Attention and mismatch negativity. Psychophysiology 1993;30:436–50.

pubmed: 8416070 doi: 10.1111/j.1469-8986.1993.tb02067.x

Garrido MI, Kilner JM, Stephan KE, Friston KJ. The mismatch negativity: a review of underlying mechanisms. Clin Neurophysiol 2009;120:453–63.

pubmed: 19181570 pmcid: 2671031 doi: 10.1016/j.clinph.2008.11.029

Sams M, Paavilainen P, Alho K, Naatanen R. Auditory frequency discrimination and event-related potentials. Electroencephalogr Clin Neurophysiol 1985;62:437–48.

pubmed: 2415340 doi: 10.1016/0168-5597(85)90054-1

van Zuijen TL, Sussman E, Winkler I, Naatanen R, Tervaniemi M. Auditory organization of sound sequences by a temporal or numerical regularity-a mismatch negativity study comparing musicians and non-musicians. Brain Res Cogn Brain Res 2005;23:270–6.

pubmed: 15820634 doi: 10.1016/j.cogbrainres.2004.10.007

van Zuijen TL, Simoens VL, Paavilainen P, Naatanen R, Tervaniemi M. Implicit, intuitive, and explicit knowledge of abstract regularities in a sound sequence: an event-related brain potential study. J Cogn Neurosci 2006;18:1292–303.

pubmed: 16859415 doi: 10.1162/jocn.2006.18.8.1292

Pekkonen E, Huotilainen M, Katila H, Karhu J, Naatanen R, Tiihonen J. Altered parallel auditory processing in schizophrenia patients. Schizophr Bull 1999;25:601–7.

pubmed: 10478792 doi: 10.1093/oxfordjournals.schbul.a033404

Naatanen R, Kahkonen S. Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review. Int J Neuropsychopharmacol 2009;12:125–35.

pubmed: 18771603 doi: 10.1017/S1461145708009322

Domján N, Csifcsák G, Drótos G, Janka Z, Szendi I. Different patterns of auditory information processing deficits in chronic schizophrenia and bipolar disorder with psychotic features. Schizophrenia Res 2012;139:253–9.

doi: 10.1016/j.schres.2012.06.002

Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 2000;57:1139–47.

pubmed: 11115327 doi: 10.1001/archpsyc.57.12.1139

Kreitschmann-Andermahr I, Rosburg T, Demme U, Gaser E, Nowak H, Sauer H. Effect of ketamine on the neuromagnetic mismatch field in healthy humans. Brain Res Cogn Brain Res 2001;12:109–16.

pubmed: 11489614 doi: 10.1016/S0926-6410(01)00043-X

Umbricht D, Koller R, Vollenweider FX, Schmid L. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry 2002;51:400–6.

pubmed: 11904134 doi: 10.1016/S0006-3223(01)01242-2

Heekeren K, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, et al. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacol 2008;199:77–88.

doi: 10.1007/s00213-008-1129-4

Neuner I, Rajkumar R, Brambilla CR, Ramkiran S, Ruch A, Orth L, et al. Simultaneous PET-MR-EEG: Technology, challenges and application in clinical neuroscience. IEEE Trans Radiat Plasma Med Sci 2019;3:377–85.

doi: 10.1109/TRPMS.2018.2886525

Elmenhorst D, Mertens K, Kroll T, Oskamp A, Ermert J, Elmenhorst EM, et al. Circadian variation of metabotropic glutamate receptor 5 availability in the rat brain. J Sleep Res 2016;25:754–61.

pubmed: 27357735 doi: 10.1111/jsr.12432

Herzog H, Langen KJ, Weirich C, Rota Kops E, Kaffanke J, Tellmann L, et al. High resolution BrainPET combined with simultaneous MRI. Nuklearmedizin 2011;50:74–82.

pubmed: 21286660 doi: 10.3413/Nukmed-0347-10-09

Burger C, Deschwanden A, Ametamey S, Johayem A, Mancosu B, Wyss M, et al. Evaluation of a bolus/infusion protocol for 11C-ABP688, a PET tracer for mGluR5. Nucl Med Biol 2010;37:845–51.

pubmed: 20870160 doi: 10.1016/j.nucmedbio.2010.04.107

Akkus F, Terbeck S, Ametamey SM, Rufer M, Treyer V, Burger C, et al. Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 2014;17:1915–22.

pubmed: 24833114 doi: 10.1017/S1461145714000716

Deschwanden A, Karolewicz B, Feyissa AM, Treyer V, Ametamey SM, Johayem A, et al. Reduced metabotropic glutamate receptor 5 density in major depression determined by [11C]ABP688 PET and postmortem study. Am J Psychiatry 2011;168:727–34.

pubmed: 21498461 pmcid: 3129412 doi: 10.1176/appi.ajp.2011.09111607

Del Guerra A, Ahmad S, Avram M, Belcari N, Berneking A, Biagi L, et al. TRIMAGE: A dedicated trimodality (PET/MR/EEG) imaging tool for schizophrenia. Eur Psychiatry 2018;50:7–20.

pubmed: 29358016 doi: 10.1016/j.eurpsy.2017.11.007

Rota Kops E, Herzog H. Template-based attenuation correction of PET in hybrid MR-PET scanners. J Nucl Med 2008;49:162P.

Brambilla, Scheins J, Issa A, Tellmann L, Herzog H, Rota Kops E, et al. Bias evaluation and reduction in 3D OP-OSEM reconstruction in dynamic equilibrium PET studies with 11C-labeled for binding potential analysis. PLoS ONE 2021;16:e0245580.

pubmed: 33481896 pmcid: 7822533 doi: 10.1371/journal.pone.0245580

Picard Y, Thompson CJ. Motion correction of PET images using multiple acquisition frames. IEEE Trans Med Imaging 1997;16:137–44.

pubmed: 9101323 doi: 10.1109/42.563659

Brambilla, Zeusseu O, Scheins J, Kops ER, Tellmann L, Shah NJ, et al. Annual Congress of the European Association of Nuclear Medicine October 12–16, 2019 Barcelona, Spain. Eur J Nucl Med Mol Imaging 2019;46:1–952.

doi: 10.1007/s00259-019-04486-2

Scheins J, Brambilla CR, Mauler J, Rota Kops E, Tellmann L, Lerche CW, et al. Image-based Motion Correction for the Siemens Hybrid MR/BrainPET Scanner. 57 Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin 2019; Bremen, Germany 2019.

Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 2003;19:224–47.

pubmed: 12874777 pmcid: 6871794 doi: 10.1002/hbm.10123

Shirer WR, Ryali S, Rykhlevskaia E, Menon V, Greicius MD. Decoding subject-driven cognitive states with whole-brain connectivity patterns. Cereb Cortex 2012;22:158–65.

pubmed: 21616982 doi: 10.1093/cercor/bhr099

Smart K, Cox SML, Nagano-Saito A, Rosa-Neto P, Leyton M, Benkelfat C. Test-retest variability of [11C]ABP688 estimates of metabotropic glutamate receptor subtype 5 availability in humans. Synapse. 2018;72:e22041.

pubmed: 29935121 doi: 10.1002/syn.22041

DeLorenzo C, Gallezot JD, Gardus J, Yang J, Planeta B, Nabulsi N, et al. In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [11C]ABP688 and [18F]FPEB. J Cereb Blood Flow Metab 2017;37:2716–27.

pubmed: 27742888 doi: 10.1177/0271678X16673646

Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods 2004;134:9–21.

pubmed: 15102499 doi: 10.1016/j.jneumeth.2003.10.009

Niazy RK, Beckmann CF, Iannetti GD, Brady JM, Smith SM. Removal of FMRI environment artifacts from EEG data using optimal basis sets. NeuroImage 2005;28:720–37.

pubmed: 16150610 doi: 10.1016/j.neuroimage.2005.06.067

Mullen TR, Kothe CAE, Chi YM, Ojeda A, Kerth T, Makeig S, et al. Real-Time neuroimaging and cognitive monitoring using wearable dry EEG. IEEE Trans bio-Med Eng 2015;62:2553–67.

doi: 10.1109/TBME.2015.2481482

Marino M, Liu Q, Koudelka V, Porcaro C, Hlinka J, Wenderoth N, et al. Adaptive optimal basis set for BCG artifact removal in simultaneous EEG-fMRI. Sci Rep. 2018;8:8902.

pubmed: 29891929 pmcid: 5995808 doi: 10.1038/s41598-018-27187-6

Gomez-Herrero G, Clercq WD, Anwar H, Kara O, Egiazarian K, Huffel SV, et al. editors. Automatic Removal of Ocular Artifacts in the EEG without an EOG Reference Channel. Proceedings of the 7th Nordic Signal Processing Symposium - NORSIG 2006; 2006 7-92006.

Bell AJ, Sejnowski TJ. An information-maximization approach to blind separation and blind deconvolution. Neural Comput 1995;7:1129–59.

pubmed: 7584893 doi: 10.1162/neco.1995.7.6.1129

Winkler I, Haufe S, Tangermann M. Automatic classification of artifactual ICA-components for artifact removal in EEG signals. Behav Brain Funct 2011;7:30.

pubmed: 21810266 pmcid: 3175453 doi: 10.1186/1744-9081-7-30

Cousineau D. Representing error bars in within-subject designs in typical software packages. The Quantitative Methods for. Psychology 2014;10:12.

Holmes SE, Gallezot J-D, Davis MT, DellaGioia N, Matuskey D, Nabulsi N, et al. Measuring the effects of ketamine on mGluR5 using [

Moghaddam B, Adams B, Verma A, Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997;17:2921–7.

pubmed: 9092613 pmcid: 6573099 doi: 10.1523/JNEUROSCI.17-08-02921.1997

Chowdhury GM, Behar KL, Cho W, Thomas MA, Rothman DL, Sanacora G. 1H-[13C]-nuclear magnetic resonance spectroscopy measures of ketamine’s effect on amino acid neurotransmitter metabolism. Biol Psychiatry 2012;71:1022–5.

pubmed: 22169441 doi: 10.1016/j.biopsych.2011.11.006

Fitzgerald K, Todd J. Making Sense of Mismatch Negativity. Front Psychiatry. 2020;11:468.

pubmed: 32595529 pmcid: 7300203 doi: 10.3389/fpsyt.2020.00468

Escera C, Alho K, Schröger E, Winkler I. Involuntary attention and distractibility as evaluated with event-related brain potentials. Audio Neurootol 2000;5:151–66.

doi: 10.1159/000013877

Lakatos P, O’Connell MN, Barczak A, McGinnis T, Neymotin S, Schroeder CE, et al. The thalamocortical circuit of auditory mismatch negativity. Biol Psychiatry 2020;87:770–80.

pubmed: 31924325 doi: 10.1016/j.biopsych.2019.10.029

Cacciaglia R, Escera C, Slabu L, Grimm S, Sanjuán A, Ventura-Campos N, et al. Involvement of the human midbrain and thalamus in auditory deviance detection. Neuropsychologia 2015;68:51–8.

pubmed: 25556848 doi: 10.1016/j.neuropsychologia.2015.01.001

Jin Y, Yang H, Zhang F, Wang J, Liu H, Yang X, et al. The medial thalamus plays an important role in the cognitive and emotional modulation of orofacial pain: a functional magnetic resonance imaging-based study. Front Neurol 2020;11:589125.

pubmed: 33551953 doi: 10.3389/fneur.2020.589125

Hwang K, Bertolero MA, Liu WB, D’Esposito M. The human thalamus is an integrative hub for functional brain networks. J Neurosci 2017;37:5594–607.

pubmed: 28450543 pmcid: 5469300 doi: 10.1523/JNEUROSCI.0067-17.2017

Bartlett EL. The organization and physiology of the auditory thalamus and its role in processing acoustic features important for speech perception. Brain Lang 2013;126:29–48.

pubmed: 23725661 pmcid: 3707394 doi: 10.1016/j.bandl.2013.03.003

Gaebler AJ, Mathiak K, Koten JW Jr., Konig AA, Koush Y, Weyer D, et al. Auditory mismatch impairments are characterized by core neural dysfunctions in schizophrenia. Brain 2015;138:1410–23.

pubmed: 25743635 pmcid: 5963408 doi: 10.1093/brain/awv049

Buckner RL, Andrews-Hanna JR, Schacter DL. The brain’s default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 2008;1124:1–38.

pubmed: 18400922 doi: 10.1196/annals.1440.011

Hahn B, Ross TJ, Stein EA. Cingulate activation increases dynamically with response speed under stimulus unpredictability. Cereb Cortex 2007;17:1664–71.

pubmed: 16963517 doi: 10.1093/cercor/bhl075

Deng Z, Wu J, Gao J, Hu Y, Zhang Y, Wang Y, et al. Segregated precuneus network and default mode network in naturalistic imaging. Brain Struct Funct 2019;224:3133–44.

pubmed: 31515678 doi: 10.1007/s00429-019-01953-2

Cunningham SI, Tomasi D, Volkow ND. Structural and functional connectivity of the precuneus and thalamus to the default mode network. Hum Brain Mapp 2017;38:938–56.

pubmed: 27739612 doi: 10.1002/hbm.23429

van den Heuvel MP, Mandl RC, Kahn RS, Hulshoff, Pol HE. Functionally linked resting-state networks reflect the underlying structural connectivity architecture of the human brain. Hum Brain Mapp 2009;30:3127–41.

pubmed: 19235882 pmcid: 6870902 doi: 10.1002/hbm.20737

van den Heuvel MP, Sporns O. Network hubs in the human brain. Trends Cogn Sci 2013;17:683–96.

pubmed: 24231140 doi: 10.1016/j.tics.2013.09.012

Gur RC, Turetsky BI, Loughead J, Waxman J, Snyder W, Ragland JD, et al. Hemodynamic responses in neural circuitries for detection of visual target and novelty: An event-related fMRI study. Hum Brain Mapp 2007;28:263–74.

pubmed: 17133387 doi: 10.1002/hbm.20319

Harms L, Parras GG, Michie PT, Malmierca MS. The role of glutamate neurotransmission in mismatch negativity (MMN), a measure of auditory synaptic plasticity and change-detection. Neuroscience 2021;456:106–13.

pubmed: 32045628 doi: 10.1016/j.neuroscience.2020.01.046

Kompus K, Westerhausen R, Craven AR, Kreegipuu K, Poldver N, Passow S, et al. Resting-state glutamatergic neurotransmission is related to the peak latency of the auditory mismatch negativity (MMN) for duration deviants: An 1H-MRS-EEG study. Psychophysiology 2015;52:1131–9.

pubmed: 25917405 doi: 10.1111/psyp.12445

Stone JM, Bramon E, Pauls A, Sumich A, McGuire PK. Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia - relationship to auditory event-related potentials. Psychiatry Res 2010;183:174–6.

pubmed: 20620033 doi: 10.1016/j.pscychresns.2010.05.004

Hwang K, Bertolero MA, Liu WB, Esposito M. The human thalamus is an integrative hub for functional brain networks. J Neurosci 2017;37:5594.

pubmed: 28450543 pmcid: 5469300 doi: 10.1523/JNEUROSCI.0067-17.2017

Jones EG. The Thalamus: Plenum Press; 1985.

Halassa MM, Acsády L. Thalamic Inhibition: Diverse Sources, Diverse Scales. Trends Neurosci 2016;39:680–93.

pubmed: 27589879 pmcid: 5048590 doi: 10.1016/j.tins.2016.08.001

Pressler RT, Regehr WG. Metabotropic glutamate receptors drive global persistent inhibition in the visual thalamus. J Neurosci 2013;33:2494–506.

pubmed: 23392677 pmcid: 3711716 doi: 10.1523/JNEUROSCI.3458-12.2013

Cheng C-H, Wang P-N, Hsu W-Y, Lin Y-Y. Inadequate inhibition of redundant auditory inputs in Alzheimer’s disease: An MEG study. Biol Psychol 2012;89:365–73.

pubmed: 22155475 doi: 10.1016/j.biopsycho.2011.11.010

Ji L-L, Zhang Y-Y, Zhang L, He B, Lu G-H. Mismatch negativity latency as a biomarker of amnestic mild cognitive impairment in Chinese rural elders. Front Aging Neurosci. 2015;7:22.

pubmed: 25814949 pmcid: 4357324 doi: 10.3389/fnagi.2015.00022

Umbricht D, Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 2005;76:1–23.

pubmed: 15927795 doi: 10.1016/j.schres.2004.12.002

Näätänen R. Attention and brain function. Hillsdale: Lawrence Erlbaum Associates, Inc. 1992.

Näätänen R, Schröger E, Karakas S, Tervaniemi M, Paavilainen P. Development of a memory trace for a complex sound in the human brain. Neuroreport 1993;4:503–6.

pubmed: 8513127 doi: 10.1097/00001756-199305000-00010